In T1D rats, weight-bearing treadmill running counteracts bone atrophy by downregulating GDF8 expression through the Activin A Receptor Type 2B (ActRIIB)/Smad2/3 pathway (113). Here, MSTN is linked to type 1 diabetes mellitus.